 | Up a level |
Keil, Andreas; Hall, Sean; Körner, Meike; Herrmann, Martin; Schmid, Ralph; Frese, Steffen R. (2016). Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan. Arthritis research & therapy, 18(243), p. 243. BioMed Central 10.1186/s13075-016-1144-5
Keil, Andreas; Frese-Schaper, Manuela; Steiner, Selina; Körner, Meike; Schmid, Ralph; Frese, Steffen R. (2015). The Topoisomerase I Inhibitor Irinotecan and the Tyrosyl-DNA Phosphodiesterase 1 Inhibitor Furamidine Synergistically Suppress Murine Lupus Nephritis. Arthritis & rheumatology, 67(7), pp. 1858-1867. Wiley-Blackwell 10.1002/art.39119
Frese-Schaper, Manuela; Keil, Andreas; Steiner, Selina; Gugger, Mathias; Körner, Meike; Kocher, Gregor; Schiffer, Lena; Anders, Hans-Joachim; Huynh-Do, Uyen; Schmid, Ralph; Frese, Steffen R. (2014). Low dose irinotecan improves advanced lupus nephritis in mice potentially by changing DNA relaxation and anti–double-stranded DNA binding. Arthritis & rheumatology, 66(8), pp. 2259-2269. Wiley-Blackwell 10.1002/art.38665
Frese-Schaper, Manuela; Keil, Andreas; Yagita, Hideo; Steiner, Selina; Falk, Werner; Schmid, Ralph; Frese, Steffen R. (2014). Influence of natural killer cells and perforin-mediated cytolysis on the development of chemically induced lung cancer in A/J mice. Cancer immunology, immunotherapy, 63(6), pp. 571-580. Springer 10.1007/s00262-014-1535-x
Lepper, Philipp M; Ott, Sebastian R; Hoppe, Hanno; Schumann, Christian; Stammberger, Uz; Bugalho, Antonio; Frese, Steffen; Schmücking, Michael; Blumstein, Norbert M; Diehm, Nicolas; Bals, Robert; Hamacher, Jürg (2011). Superior Vena Cava Syndrome (SVCS) in Thoracic Malignancies. Respiratory care, 56(5), pp. 653-66. Irving, Tex.: Daedalus Enterprises 10.4187/respcare.00947
Frese, Steffen; Diamond, Betty (2011). Structural modification of DNA--a therapeutic option in SLE? Nature reviews - rheumatology, 7(12), pp. 733-8. New York, N.Y.: Nature Publishing Group 10.1038/nrrheum.2011.153
Frese-Schaper, Manuela; Schardt, Julian A; Sakai, Toshiyuki; Carboni, Giovanni L; Schmid, Ralph A; Frese, Steffen (2010). Inhibition of tissue transglutaminase sensitizes TRAIL-resistant lung cancer cells through upregulation of death receptor 5. FEBS letters, 584(13), pp. 2867-71. Amsterdam: Elsevier 10.1016/j.febslet.2010.04.072
Frese-Schaper, Manuela; Zbaeren, Jakob; Gugger, Mathias; Monestier, Marc; Frese, Steffen (2010). Reversal of established lupus nephritis and prolonged survival of New Zealand black x New Zealand white mice treated with the topoisomerase I inhibitor irinotecan. Journal of immunology, 184(4), pp. 2175-82. Bethesda, Md.: American Association of Immunologists 10.4049/jimmunol.0903153
Schneider-Jakob, S; Corazza, N; Badmann, A; Sidler, D; Stuber-Roos, R; Keogh, A; Frese, S; Tschan, M; Brunner, T (2010). Synergistic induction of cell death in liver tumor cells by TRAIL and chemotherapeutic drugs via the BH3-only proteins Bim and Bid. Cell death & disease, 1(e86), e86. London: Nature Publishing Group 10.1038/cddis.2010.66
Takeda, Kazuyoshi; Kojima, Yuko; Ikejima, Kenichi; Harada, Kenichi; Yamashina, Shunhei; Okumura, Kyoko; Aoyama, Tomonori; Frese, Steffen; Ikeda, Hiroko; Haynes, Nicole M; Cretney, Erika; Yagita, Hideo; Sueyoshi, Noriyoshi; Sato, Nobuhiro; Nakanuma, Yasuni; Smyth, Mark J; Okumura, Ko (2008). Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease. Proceedings of the National Academy of Sciences of the United States of America - PNAS, 105(31), pp. 10895-900. Washington, D.C.: National Academy of Sciences NAS 10.1073/pnas.0802702105
Plock, Jan; Frese, Steffen; Keogh, Adrian; Bisch-Knaden, Sonja; Ayuni, Erick; Corazza, Nadia; Weikert, Christian; Jakob, Stephan; Erni, Dominique; Dufour, Jean-François; Brunner, Thomas; Candinas, Daniel; Stroka, Deborah (2007). Activation of non-ischemic, hypoxia-inducible signalling pathways up-regulate cytoprotective genes in the murine liver. Journal of hepatology, 47(4), pp. 538-45. Amsterdam: Elsevier 10.1016/j.jhep.2007.04.016
Pirnia, Farzaneh; Frese, Steffen; Gloor, Beat; Hotz, Michel A; Luethi, Alexander; Gugger, Mathias; Betticher, Daniel C; Borner, Markus M (2006). Ex vivo assessment of chemotherapy-induced apoptosis and associated molecular changes in patient tumor samples. Anticancer research, 26(3A), pp. 1765-72. Kapandriti: International Inst. of Anticancer Research
Corazza, Nadia; Jakob, Sabine; Schaer, Corinne; Frese, Steffen; Keogh, Adrian; Stroka, Deborah; Kassahn, Daniela; Torgler, Ralph; Mueller, Christoph; Schneider, Pascal; Brunner, Thomas (2006). TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality. Journal of clinical investigation, 116(9), pp. 2493-9. Ann Arbor, Mich.: American Society for Clinical Investigation 10.1172/JCI27726
Frese, Steffen; Frese-Schaper, Manuela; Andres, Anne-Catherine; Miescher, Daniela; Zumkehr, Beatrice; Schmid, Ralph A (2006). Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5. Cancer research, 66(11), pp. 5867-74. Birmingham, Ala.: American Association for Cancer Research AACR 10.1158/0008-5472.CAN-05-3544
Kuester, JR; Frese, S; Stein, RM; Roth, T; Beshay, M; Schmid, RA (2006). Treatment of primary spontaneous pneumothorax in Switzerland: results of a survey. Interactive cardiovascular and thoracic surgery, 5(2), pp. 139-144. Oxford: Oxford University Press 10.1510/icvts.2005.122770
Keogh-Stroka, Deborah M.; Plock, Jan Alexander; Beldi, Guido; Frese, Steffen R.; Keogh, Adrian; Bisch-Knaden, Sonja Maria; Dufour, Jean-François; Brunner, Thomas; Candinas, Daniel (2006). Temporary hypoxic stress protects the liver from Fas-mediated apoptosis and ischemia reperfusion injury. In: 93. Jahreskongress der Schweizerischen Gesellschaft für Chirurgie. Lugano, Switzerland. 21.-23.6.2006.
